Sanofi Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method
Sanofi (SNYNF) reported Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method of -EUR 290.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod · last filed 2026-02-17
| Period end | Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method 6 month | Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method 6 month as first filed | Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method 12 month | Adjustments For Undistributed Profits Of Investments Accounted For Using Equity Method 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -290.00M EUR 20-F · filed 2026-02-17 | |||
| 2025-06-30 | 15.00M EUR 6-K · filed 2025-10-27 | |||
| 2024-12-31 | -82.00M EUR 20-F · filed 2026-02-17 | |||
| 2024-06-30 | -96.00M EUR 6-K · filed 2025-10-27 | -110.00M EUR 6-K · filed 2024-07-25 | ||
| 2023-12-31 | -293.00M EUR 20-F · filed 2026-02-17 | -295.00M EUR 20-F · filed 2024-02-23 | ||
| 2023-06-30 | -196.00M EUR 6-K · filed 2024-07-25 | |||
| 2022-12-31 | 45.00M EUR 20-F · filed 2025-02-13 | 48.00M EUR 20-F · filed 2023-02-24 | ||
| 2022-06-30 | 53.00M EUR 6-K · filed 2023-07-28 | |||
| 2021-12-31 | 15.00M EUR 20-F · filed 2024-02-23 | |||
| 2021-06-30 | 8.00M EUR 6-K · filed 2022-07-28 | |||
| 2020-12-31 | 339.00M EUR 20-F · filed 2023-02-24 | |||
| 2020-06-30 | 327.00M EUR 6-K · filed 2021-07-29 | |||
| 2019-12-31 | 192.00M EUR 20-F · filed 2022-02-23 | |||
| 2019-06-30 | 82.00M EUR 6-K · filed 2020-07-29 | |||
| 2018-12-31 | 471.00M EUR 20-F · filed 2021-03-04 | |||
| 2017-12-31 | 47.00M EUR 20-F · filed 2020-03-05 | -66.00M EUR 20-F/A · filed 2018-03-16 | ||
| 2016-12-31 | 85.00M EUR 20-F · filed 2019-03-08 | -83.00M EUR 20-F/A · filed 2018-03-16 | ||
| 2015-12-31 | 115.00M EUR 20-F/A · filed 2018-03-16 |